Cdk9 Inhibitor II - CAS 140651-18-9

INQUIRY Add to cart

For Research Use Only | Not For Clinical Use

Description	The Cdk9 Inhibitor II, also referenced under CAS 140651-18-9, controls the biological activity of Cdk9. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.
Solubility	DMSO: 10 mg/mL; ethanol: 5 mg/mL
Assay	≥95% (HPLC)
Color	orange
Form	solid; protect from light
Size	5MG
Storage Conditions	+2C to +8C

CDK9 Modulates Circadian Clock by Attenuating REV-ERBα Activity

Jiali Ou, Huilin Li, Peiyuan Qiu, Qing Li, Hung-Chun Chang, Yun-Chi Tang

Biochem Biophys Res Commun. 2019 Jun 11;513(4):967-973.

PMID: 31005255

Cyclin T1/CDK9 Interacts With Influenza A Virus Polymerase and Facilitates Its Association With Cellular RNA Polymerase II

Junjie Zhang, Gang Li, Xin Ye

J Virol. 2010 Dec;84(24):12619-27.

PMID: 20943989

Polo-like Kinase 1 Inhibits the Activity of Positive Transcription Elongation Factor of RNA Pol II B (P-TEFb)

Liangzhen Jiang, Yan Huang, Min Deng, Ting Liu, Wenbin Lai, Xin Ye

PLoS One. 2013 Aug 16;8(8):e72289.

PMID: 23977272

Positive Transcription Elongation Factor B (P-TEFb) Is a Therapeutic Target in Human Multiple Myeloma

Yu Zhang, Liang Zhou, Yun Leng, Yun Dai, Robert Z Orlowski, Steven Grant

Oncotarget. 2017 Aug 1;8(35):59476-59491.

PMID: 28938651

* Products or Services Interested: Cdk9 Inhibitor II - CAS 140651-18-9 (140651-18-9)
* Your question
* Name
* Email
Verification Code

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.

Online Inquiry